---
title: "GHK-Cu"
slug: "ghk-cu"
type: "compound"
category: "Recovery"
url: "https://peptidesciencethailand.com/compounds/ghk-cu"
description: "GHK-Cu modulates 4,000+ genes for collagen, wound healing, and anti-aging. How the copper peptide works, evidence reviewed, and what to expect."
---
# GHK-Cu

*Copper Peptide Complex, 4,000+ Gene Modulator for Regeneration*

**Category:** Recovery  
**Format:** Lyophilized Vial  
**Amount:** 50mg  
**Purity:** >99.0% (HPLC)

## Overview

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with the sequence Gly-His-Lys that possesses a strong affinity for copper(II) ions. First identified in human plasma by Dr. Loren Pickart in 1973, GHK-Cu was isolated from albumin and found to be present in blood plasma, saliva, and urine. Pickart discovered that old human plasma, depleted of GHK-Cu, produced liver cells that synthesized fibrinogen at rates typical of old tissue, while adding GHK-Cu back to the depleted plasma restored youthful protein synthesis patterns, a finding that launched decades of research into this remarkable peptide's regenerative capabilities.

What makes GHK-Cu uniquely significant in peptide research is the scope of its biological influence. Broad gene expression studies using the Connectivity Map (cMap) database at the Broad Institute have revealed that GHK-Cu modulates the expression of over 4,000 human genes, approximately 6% of the human genome. This extraordinary breadth of gene modulation is unmatched by virtually any other single molecule studied. The affected genes fall into functional categories including tissue remodeling, antioxidant defense, anti-inflammatory response, nerve function, DNA repair, and stem cell biology.

GHK-Cu's mechanism begins with its copper-binding function. Copper is an essential cofactor for numerous enzymes involved in tissue remodeling, including lysyl oxidase (required for collagen and elastin cross-linking), superoxide dismutase (SOD, a critical antioxidant enzyme), and cytochrome c oxidase (essential for mitochondrial energy production). By delivering copper to these enzyme systems and modulating their gene expression simultaneously, GHK-Cu creates a coordinated regenerative response that exceeds what either copper supplementation or gene modulation alone could achieve.

Collagen synthesis is one of GHK-Cu's most extensively documented effects. Research has shown it stimulates the production of collagen types I, III, and V, the primary structural proteins of skin, tendons, and blood vessels. Simultaneously, it activates decorin (a proteoglycan that regulates collagen fibril assembly), ensuring newly synthesized collagen is properly organized into functional tissue rather than disordered scar tissue. This organized collagen production underlies GHK-Cu's wound healing and skin rejuvenation properties.

GHK-Cu's anti-inflammatory effects operate through suppression of NF-κB signaling, reduction of TNF-α and IL-6 expression, and modulation of TGF-β (transforming growth factor beta) from scarring-associated isoforms (TGF-β1) toward regenerative isoforms (TGF-β3). This TGF-β isoform switching is particularly significant, TGF-β1 drives fibrotic scar formation, while TGF-β3 promotes scarless regenerative healing. Research in wound healing models has demonstrated significantly reduced scar formation when GHK-Cu is applied to healing tissue.

The peptide's effects on stem cell biology have generated particular research interest. GHK-Cu has been shown to increase the expression of stem cell markers including p63, integrin β1, and Sox2, and to promote the proliferation of basal epithelial stem cells. These effects on stem cell activation contribute to GHK-Cu's tissue renewal and anti-aging properties, as stem cell depletion is a recognized hallmark of aging.

In dermatological research, GHK-Cu has demonstrated ability to increase skin thickness and elasticity, reduce fine lines and photodamage, improve skin barrier function, and accelerate wound healing. Multiple clinical studies have confirmed improvements in skin appearance and function with topical GHK-Cu application, making it one of the few research peptides with both topical and systemic applications.

GHK-Cu levels in human plasma decline significantly with age, from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. This age-related decline parallels the loss of regenerative capacity observed in aging tissues, suggesting that GHK-Cu depletion contributes to reduced tissue repair and renewal with advancing age.

specialist oversight is important for systemic GHK-Cu protocols because copper metabolism varies among individuals, and conditions affecting copper homeostasis (such as Wilson's disease) contraindicate supplemental copper-peptide administration. Monitoring copper levels ensures the protocol remains within safe parameters.

## Mechanism of Action

### Step 1: Copper Delivery to Enzyme Systems

GHK-Cu delivers copper(II) ions to critical enzyme systems including lysyl oxidase (collagen cross-linking), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (mitochondrial energy), activating these enzymatic pathways.

### Step 2: Massive Gene Expression Modulation

GHK-Cu modulates 4,000+ human genes (~6% of genome), coordinating expression changes across tissue remodeling, antioxidant defense, anti-inflammatory response, DNA repair, nerve function, and stem cell biology categories.

### Step 3: Collagen & Decorin Synthesis

Stimulation of collagen types I, III, and V production combined with decorin activation ensures newly synthesized collagen is properly organized into functional tissue rather than disordered scar tissue.

### Step 4: TGF-β Isoform Switching

GHK-Cu modulates TGF-β from scarring-associated TGF-β1 toward regenerative TGF-β3, promoting scarless healing rather than fibrotic scar formation. This isoform switching is a unique and significant regenerative mechanism.

### Step 5: Stem Cell Activation & Tissue Renewal

GHK-Cu increases expression of stem cell markers (p63, integrin β1, Sox2) and promotes basal stem cell proliferation, enhancing the tissue's inherent capacity for self-renewal and repair.

## Researched Benefits

### Unprecedented Gene Modulation

GHK-Cu modulates over 4,000 human genes, approximately 6% of the genome, creating coordinated regenerative responses across multiple biological systems simultaneously. No other single molecule studied shows this breadth of gene-level influence on tissue remodeling and repair.

### Collagen & Skin Regeneration

GHK-Cu stimulates production of collagen types I, III, and V with proper fibril organization through decorin activation. Clinical studies have demonstrated increased skin thickness, improved elasticity, reduced fine lines, and accelerated wound healing with both topical and systemic applications.

### Scarless Healing Promotion

Through TGF-β isoform switching from scarring TGF-β1 to regenerative TGF-β3, GHK-Cu promotes tissue repair that more closely resembles original tissue structure rather than fibrotic scar tissue. This has implications for both cosmetic outcomes and functional tissue recovery.

### Antioxidant & Anti-Inflammatory

GHK-Cu enhances antioxidant defense through SOD activation and reduces inflammation via NF-κB and cytokine suppression. These dual protective effects create an optimal microenvironment for tissue regeneration while guarding against oxidative damage.

## Dosage & Administration

| Parameter | Detail |
| --- | --- |
| Protocol | 1-2mg administered subcutaneously daily; also used topically in dermatological applications |
| Route | Subcutaneous injection or topical application |
| Duration | 4-8 weeks for systemic use; ongoing for topical applications |
| Cycle Notes | Systemic protocols typically run 4-8 weeks with rest periods. Topical application can be ongoing. Some protocols combine both routes, systemic for tissue repair with topical for skin-specific benefits. |
| Reconstitution | Reconstitute with bacteriostatic water. Store reconstituted solution at 2-8°C protected from light. GHK-Cu solution may have a slight blue-green tint from copper, this is normal. |

> **Specialist note:** A specialist would assess copper metabolism status before initiating systemic GHK-Cu. Individuals with Wilson's disease or other copper metabolism disorders should not use GHK-Cu. Baseline copper and ceruloplasmin levels may be checked to ensure safe supplementation.

## Compound Reference Data

| Property | Value |
| --- | --- |
| Format | Lyophilized Powder |
| Amount | 50mg per vial |
| Purity | >99.0% |
| Purity Method | HPLC (High-Performance Liquid Chromatography) |
| Sequence | Gly-His-Lys · Cu²⁺ |
| Molecular Weight | 403.93 g/mol (as copper complex) |
| Storage | Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C. Protect from light. |
| Appearance | Blue to blue-green lyophilized powder (copper coloration is normal) |

## Medical Guidance

GHK-Cu delivers supplemental copper bound to a peptide carrier, which means copper metabolism assessment is essential before systemic use. Wilson's disease (a genetic condition causing copper accumulation) is an absolute contraindication. A specialist would evaluate copper status through ceruloplasmin and serum copper testing. Additionally, individuals with liver conditions should be assessed, as copper metabolism is liver-dependent.

## Frequently Asked Questions

### How does GHK-Cu modulate so many genes?

GHK-Cu's extraordinary gene modulation (4,000+ genes, ~6% of the genome) occurs through its dual function as both a copper delivery system and a signaling molecule. Copper is a cofactor for numerous enzymes and transcription factors, and GHK-Cu's peptide component adds additional regulatory signaling. The Connectivity Map database at the Broad Institute confirmed this unprecedented scope of gene modulation across tissue remodeling, antioxidant defense, and stem cell categories.

### What medical guidance applies to GHK-Cu?

GHK-Cu is a compound studied in clinical research that should only be used under qualified medical supervision for systemic (injectable) use. Doctor consultation ensures copper metabolism is assessed (ruling out Wilson's disease), appropriate dosing is determined, and the protocol is integrated with overall health plan. This is essential for safety because copper homeostasis varies among individuals.

### Can GHK-Cu be used both topically and systemically?

Yes, GHK-Cu has documented benefits through both routes of administration. Topical application has clinical evidence for skin rejuvenation, wound healing, and cosmetic improvement. Systemic (subcutaneous) administration provides broader tissue repair and anti-aging effects through gene modulation across multiple organ systems. A specialist may recommend one or both routes depending on your goals.

### Why do GHK-Cu levels decline with age?

Plasma GHK-Cu levels decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, a 60% reduction. This decline parallels the loss of regenerative capacity observed in aging tissues, suggesting GHK-Cu depletion contributes to reduced tissue repair. Researchers hypothesize that declining GHK-Cu contributes to the progressive loss of the body's ability to maintain and repair tissue as it ages.

### What is the significance of TGF-β isoform switching?

TGF-β isoform switching is one of GHK-Cu's most unique properties. TGF-β1 (the dominant form in adult wound healing) drives fibrotic scar formation, while TGF-β3 (dominant in fetal wound healing, which is scarless) promotes regenerative repair. GHK-Cu shifts this balance toward TGF-β3, promoting healing that resembles original tissue structure rather than scar tissue, a property with significant implications for injury recovery and cosmetic outcomes.

## Related Compounds

- /compounds/bpc-157
- /compounds/tb-500
- /compounds/epithalon

## Comparisons

- /compare/epithalon-vs-ghk-cu